Phase II Multicenter Trial of the Austrian AGO With the Combination of Liposomal Doxorubicin (Myocet) and Carboplatin in Primary Advanced or Metastatic and Recurrent Endometrial Cancer.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Carboplatin (Primary) ; Doxorubicin liposomal (Primary)
- Indications Endometrial cancer
- Focus Therapeutic Use
- 20 Jun 2013 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently' (last verified Feb 2011).
- 09 Apr 2010 New trial record